1. Hillarp A, Strandberg K, Gustafsson KM, Lindahl TL. Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays. J Thromb Haemost. 2020 Apr 15. doi: 10.1111/jth.14829. Online ahead of print.
2. Macwan AS, Boknäs N, Ntzouni MP, Ramström S, Gibbins JM, Faxälv L, Lindahl TL. Gradient-dependent inhibition of stimulatory signaling from platelet G protein-coupled receptors. Haematologica, 2019;104:1482-1492.
3. Alfredsson J, Swahn E, Gustafsson KM, Janzon M, Jonasson L, Logander E, Nilsson L, Lindahl TL. Individual long-term variation of platelet reactivity in patients with dual antiplatelet therapy after myocardial infarction. Platelets. 2019;30:572-8.
4. Heenkenda MK, Lindahl TL, Osman A. Frequency of Ala120Thr PAR4 variant varies widely across Sub-Saharan African populations. Blood. 2018;132:2103-6.
5. Tunströmer K, Faxälv L, Boknäs N, Lindahl TL. Quantification of Platelet Contractile Movements during Thrombus Formation. Thromb Haemost. 2018;118:1600-11.
6. Hillarp A, Strandberg K, Baghaei F, Fagerberg Blixter I, Gustafsson KM, Lindahl TL. Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays. Scand J Clin Lab Invest. 2018 Nov - Dec;78(7-8):575-583.
7. Boknäs N, Ramström S, Faxälv L, Lindahl TL. Flow cytometry-based platelet function testing is predictive of symptom burden in a cohort of bleeders. Platelets. 2018 Jul;29(5):512-519.
8. Sánchez Centellas D, Gudlur S, Vicente-Carrillo A, Ramström S, Lindahl TL. A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets. Thromb Res. 2017;154:84-92.
9. Boknäs N, Faxälv L, Sanchez Centellas D, Wallstedt M, Ramström S, Grenegård M, Lindahl TL. Thrombin-induced platelet activation via PAR4: pivotal role for exosite II. Thromb Haemost. 2014;112:558-65.
10. Boknäs N, Faxälv L, Ström JO, Tengvall P, Theodorsson E, Ramström S, Lindahl TL. Response: Platelets do not generate activated factor XII--how inappropriate experimental models have led to misleading conclusions. Blood. 2014;124:1692-4.
